Target intelligence / Profile preview

Candida species (pathogenic yeast)

Molecular classification
Other (opportunistic fungal pathogen, yeast)
01

Overview

Pathogenic yeast in the urogenital tract refers primarily to infection by Candida species, a genus of opportunistic fungi that are part of the normal human microbiota but can cause disease (candidiasis) when host defenses are compromised. The most common species, Candida albicans, along with others such as C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei, can cause vaginitis, balanitis, and, more rarely, urinary tract infections. Diagnosis is based on symptoms, microscopy, and laboratory identification of Candida. Treatments include topical or systemic antifungal agents. Drug resistance, recurrence, and complications may occur, particularly in at-risk populations such as diabetics, pregnant women, and immunocompromised patients.

Other names
Pathogenic yeast (Candida)Urogenital CandidaUrogenital yeastVaginal yeastGenital CandidaPathogenic fungi (urogenital)
02

Mechanism of action

Inhibition of fungal cell membrane synthesis (azole and polyene classes); Inhibition of β-(1,3)-D-glucan synthesis in fungal cell wall (echinocandins)

03

Biological functions

Pathogenesis (infection)Biofilm formationImmune evasionTissue invasion
04

Disease associations

Infection (urogenital)Candidiasis (vulvovaginal, balanitis, urinary tract infection)Other (opportunistic infections especially in immunocompromised and hospitalized individuals)
05

Safety considerations

Antifungal resistance (especially in non-albicans species)Toxicity of systemic antifungalsRecurrenceDisruption of normal floraPotential for severe systemic infection in the immunocompromised
06

Interacting drugs

Fluconazole

6 more in the full profile.

07

Biomarkers

Positive fungal culture from urogenital sampleCandida PCR/NAAT testingMicroscopy (yeast forms, pseudohyphae)Elevated white blood cells in urine or secretionsClinical symptoms (vaginal discharge, itching, erythema, burning)

Beyond the preview

Go deeper on Candida species (pathogenic yeast).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida species (pathogenic yeast).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call